Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;37(5):900-909.
doi: 10.1111/fcp.12896. Epub 2023 Mar 30.

A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms

Affiliations
Review

A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms

Maryam Golmohammadi et al. Fundam Clin Pharmacol. 2023 Oct.

Abstract

Bladder cancer (BC) is known as a prevalent genitourinary malignancy and has a significant mortality rate worldwide. Despite recent therapeutic approaches, the recurrence rate is high, highlighting the need for a new strategy to reduce the BC cell progression. Quercetin, a flavonoid compound, demonstrated promising anticancer properties and could be used in the management of various malignancies such as BC. This comprehensive review summarized quercetin's cellular and molecular mechanisms underlying anticancer activities. The study's findings indicated that quercetin prevents the proliferation of the human BC cell line, promotes apoptosis of BIU-87 cells, reduces the expression of p-P70S6K, and induces apoptosis by p-AMPK. Moreover, quercetin restricts tumor growth through the AMPK/mTOR cascade and prevents colony formation of human BC cells by triggering DNA damage. Studying this review article will help researchers better understand quercetin's functional role in the prevention and treatment of BC.

Keywords: apoptosis; bladder cancer; cell proliferation; oxidative stress; quercetin.

PubMed Disclaimer

References

REFERENCES

    1. Richters A, Aben KK, Kiemeney LA. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895-1904. doi:10.1007/s00345-019-02984-4
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492
    1. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239-249. doi:10.1016/S0140-6736(09)60491-8
    1. Shokeir A. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 2004;93(2):216-220. doi:10.1111/j.1464-410X.2004.04588.x
    1. Pavanello S, Carta A, Mastrangelo G, Campisi M, Arici C, Porru S. Relationship between telomere length, genetic traits and environmental/occupational exposures in bladder cancer risk by structural equation modelling. Int J Environ Res Public Health. 2018;15(1):5. doi:10.3390/ijerph15010005

LinkOut - more resources